Suppr超能文献

不强化药物治疗的原因:区分“临床惰性”与适当治疗。

Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care.

作者信息

Safford Monika M, Shewchuk Richard, Qu Haiyan, Williams Jessica H, Estrada Carlos A, Ovalle Fernando, Allison Jeroan J

机构信息

University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

J Gen Intern Med. 2007 Dec;22(12):1648-55. doi: 10.1007/s11606-007-0433-8. Epub 2007 Oct 24.

Abstract

BACKGROUND

"Clinical inertia" has been defined as inaction by physicians caring for patients with uncontrolled risk factors such as blood pressure. Some have proposed that it accounts for up to 80% of cardiovascular events, potentially an important quality problem. However, reasons for so-called clinical inertia are poorly understood.

OBJECTIVE

To derive an empiric conceptual model of clinical inertia as a subset of all clinical inactions from the physician perspective.

METHODS

We used Nominal Group panels of practicing physicians to identify reasons why they do not intensify medications when seeing an established patient with uncontrolled blood pressure.

MEASUREMENTS AND MAIN RESULTS

We stopped at 2 groups (N = 6 and 7, respectively) because of the high degree of agreement on reasons for not intensifying, indicating saturation. A third group of clinicians (N = 9) independently sorted the reasons generated by the Nominal Groups. Using multidimensional scaling and hierarchical cluster analysis, we translated the sorting results into a cognitive map that represents an empirically derived model of clinical inaction from the physician's perspective. The model shows that much inaction may in fact be clinically appropriate care.

CONCLUSIONS/RECOMMENDATIONS: Many reasons offered by physicians for not intensifying medications suggest that low rates of intensification do not necessarily reflect poor quality of care. The empirically derived model of clinical inaction can be used as a guide to construct performance measures for monitoring clinical inertia that better focus on true quality problems.

摘要

背景

“临床惰性”被定义为负责治疗具有如血压等未得到控制的危险因素的患者的医生的不作为。一些人提出,它占心血管事件的比例高达80%,这可能是一个重要的质量问题。然而,所谓临床惰性的原因却知之甚少。

目的

从医生的角度推导作为所有临床不作为子集的临床惰性的经验概念模型。

方法

我们使用执业医生名义小组来确定他们在诊治患有未控制血压的老患者时不增加药物治疗的原因。

测量和主要结果

由于在不增加治疗的原因上高度一致,我们在两组(分别为N = 6和7)时停止,表明达到饱和。第三组临床医生(N = 9)独立对名义小组产生的原因进行分类。使用多维标度法和层次聚类分析,我们将分类结果转化为一个认知图,该图代表了从医生角度经验推导得出的临床不作为模型。该模型表明,许多不作为实际上可能是临床上适当的治疗。

结论/建议:医生给出的许多不增加药物治疗的原因表明,增加治疗的低比率不一定反映护理质量差。经验推导得出的临床不作为模型可作为构建用于监测临床惰性的绩效指标的指南,这些指标能更好地聚焦于真正的质量问题。

相似文献

1
Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care.
J Gen Intern Med. 2007 Dec;22(12):1648-55. doi: 10.1007/s11606-007-0433-8. Epub 2007 Oct 24.
3
Clinical inertia: a common barrier to changing provider prescribing behavior.
Jt Comm J Qual Patient Saf. 2007 May;33(5):277-85. doi: 10.1016/s1553-7250(07)33032-8.
5
Therapeutic inertia and contributing factors among ambulatory patients with hypertension.
BMC Cardiovasc Disord. 2024 Sep 27;24(1):523. doi: 10.1186/s12872-024-04109-1.
7
Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries.
J Hum Hypertens. 2009 Mar;23(3):151-9. doi: 10.1038/jhh.2008.117. Epub 2008 Sep 11.
9
Physician and patient characteristics associated with clinical inertia in blood pressure control.
J Clin Hypertens (Greenwich). 2013 Nov;15(11):820-4. doi: 10.1111/jch.12179. Epub 2013 Aug 7.

引用本文的文献

1
Association of Questionnaire-Assessed Fall Risk With Uncontrolled Blood Pressure and Therapeutic Inertia Among Older Adults.
J Clin Hypertens (Greenwich). 2025 Jan;27(1):e14933. doi: 10.1111/jch.14933. Epub 2024 Nov 5.
2
Barriers to Optimal Clinician Guideline Adherence in Management of Markedly Elevated Blood Pressure: A Qualitative Study.
JAMA Netw Open. 2024 Aug 1;7(8):e2426135. doi: 10.1001/jamanetworkopen.2024.26135.
4
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus.
Nat Rev Endocrinol. 2024 Jul;20(7):426-440. doi: 10.1038/s41574-024-00973-1. Epub 2024 Apr 8.
5
Psychological Distress and Hypertension Diagnostic Testing: Is There Anything to Worry About?
Am J Hypertens. 2024 Jan 1;37(1):18-20. doi: 10.1093/ajh/hpad096.
7
Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease.
Diabetes Ther. 2023 Aug;14(8):1241-1266. doi: 10.1007/s13300-023-01431-3. Epub 2023 Jun 16.
8
Overcoming Therapeutic Inertia as the Achilles' Heel for Improving Suboptimal Diabetes Care: An Integrative Review.
Endocrinol Metab (Seoul). 2023 Feb;38(1):34-42. doi: 10.3803/EnM.2022.1649. Epub 2023 Feb 16.

本文引用的文献

1
Patient complexity: more than comorbidity. the vector model of complexity.
J Gen Intern Med. 2007 Dec;22 Suppl 3(Suppl 3):382-90. doi: 10.1007/s11606-007-0307-0.
2
General internists' views on pay-for-performance and public reporting of quality scores: a national survey.
Health Aff (Millwood). 2007 Mar-Apr;26(2):492-9. doi: 10.1377/hlthaff.26.2.492.
3
Using a modified nominal group technique to elicit director of nursing input for an osteoporosis intervention.
J Am Med Dir Assoc. 2006 Sep;7(7):420-5. doi: 10.1016/j.jamda.2006.05.004. Epub 2006 Jul 17.
4
Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.
Ann Intern Med. 2006 Apr 4;144(7):475-84. doi: 10.7326/0003-4819-144-7-200604040-00006.
5
Can money buy quality? Physician response to pay for performance.
Issue Brief Cent Stud Health Syst Change. 2005 Dec(102):1-4.
6
Commentary--improving diabetes care by combating clinical inertia.
Health Serv Res. 2005 Dec;40(6 Pt 1):1854-61. doi: 10.1111/j.1475-6773.2005.00437.x.
9
Clinical inertia in the management of Type 2 diabetes metabolic risk factors.
Diabet Med. 2004 Feb;21(2):150-5. doi: 10.1111/j.1464-5491.2004.01095.x.
10
Hypertension control: how well are we doing?
Arch Intern Med. 2003;163(22):2705-11. doi: 10.1001/archinte.163.22.2705.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验